BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28840384)

  • 1. Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis.
    Papathemelis T; Scharl S; Kronberger K; Gerken M; Scharl A; Pauer A; Klinkhammer-Schalke M
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2555-2562. PubMed ID: 28840384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis.
    Papathemelis T; Hassas D; Gerken M; Klinkhammer-Schalke M; Scharl A; Lux MP; Beckmann MW; Scharl S
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):2019-2027. PubMed ID: 30039227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival impact based on the thoroughness of pelvic lymphadenectomy in intermediate- or high-risk groups of endometrioid-type endometrial cancer: A multi-center retrospective cohort analysis.
    Kim TH; Kim HS; Kim TJ; Chang SJ; Kim DY; Ryu SY; Kim BG; Kim YT; Bae DS; Ryu HS; Nam JH
    Gynecol Oncol; 2016 Jun; 141(3):440-446. PubMed ID: 27020700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedure.
    Papathemelis T; Oppermann H; Grafl S; Gerken M; Pauer A; Scharl S; Scharl A; Inwald E; Ignatov A; Ortmann O; Klinkhammer-Schalke M; Hein A; Beckmann MW; Lux MP
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):961-969. PubMed ID: 31901975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease.
    Ducie JA; Eriksson AGZ; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Soslow RA; Keeney GL; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2017 Dec; 147(3):541-548. PubMed ID: 28965698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
    Kokcu A; Kurtoglu E; Celik H; Kefeli M; Tosun M; Onal M
    Asian Pac J Cancer Prev; 2015; 16(13):5331-5. PubMed ID: 26225674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors that mitigate the role of paraaortic lymphadenectomy in uterine endometrioid cancer.
    Kumar S; Mariani A; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2013 Sep; 130(3):441-5. PubMed ID: 23747331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
    AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
    Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy?
    Lowery WJ; Gehrig PA; Ko E; Secord AA; Chino J; Havrilesky LJ
    Gynecol Oncol; 2012 Jul; 126(1):12-5. PubMed ID: 22588178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis.
    Todo Y; Kato H; Kaneuchi M; Watari H; Takeda M; Sakuragi N
    Lancet; 2010 Apr; 375(9721):1165-72. PubMed ID: 20188410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modern tendencies in the surgical treatment of the early detected endometrial cancers--with or without lymph node dissection].
    Akush Ginekol (Sofiia); 2008; 47(6):22-5. PubMed ID: 19230261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a sentinel lymph node and a selective lymphadenectomy algorithm in patients with endometrioid endometrial carcinoma and limited myometrial invasion.
    Zahl Eriksson AG; Ducie J; Ali N; McGree ME; Weaver AL; Bogani G; Cliby WA; Dowdy SC; Bakkum-Gamez JN; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2016 Mar; 140(3):394-9. PubMed ID: 26747778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of paraaortic lymphadenectomy for endometrial cancer with positive pelvic lymph nodes: A Korean Radiation Oncology Group study (KROG 13-17).
    Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M; Jeong JU; Nam TK
    Eur J Surg Oncol; 2016 Oct; 42(10):1497-505. PubMed ID: 27450638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma.
    Basaran D; Bruce S; Aviki EM; Mueller JJ; Broach VA; Cadoo K; Soslow RA; Alektiar KM; Abu-Rustum NR; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):70-76. PubMed ID: 31739992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer.
    Dowdy SC; Borah BJ; Bakkum-Gamez JN; Weaver AL; McGree ME; Haas LR; Keeney GL; Mariani A; Podratz KC
    Gynecol Oncol; 2012 Oct; 127(1):5-10. PubMed ID: 22771890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
    Abu-Rustum NR; Chi DS; Leitao M; Oke EA; Hensley ML; Alektiar KM; Barakat RR
    Gynecol Oncol; 2008 Oct; 111(1):46-8. PubMed ID: 18657853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.